Association between Hepato-Biliary Status and HbA1C in Type 2 Diabetes Mellitus with Coronary Artery Disease (CAD)
- 1 Department of Biochemistry, MGMCRI, SBV University, Pilliyarkuppam, Pondicherry, India
- 2 Department of Biochemistry, MGMCRI, SBV University, Pilliyarkuppam, Pondicherry, India
- 3 Department of Biochemistry, MGMCRI, SBV University, Pilliyarkuppam, Pondicherry, India
- 4 Department of Biochemistry, MGMCRI, SBV University, Pilliyarkuppam, Pondicherry, India
- 5 Department of Biochemistry, MGMCRI, SBV University, Pilliyarkuppam, Pondicherry, India
- 6 Department of Biochemistry, MGMCRI, SBV University, Pilliyarkuppam, Pondicherry, India
Abstract
Bilirubin has both antioxidant activity and cardioprotective potential. Decreased levels are associated with predicting CAD. Recent studies showed that bilirubin has inverse correlation with glycemic status. So in this we evaluated the role of Hepatobiliary function as a marker of predictor CAD in patient with T2DM. Total 100 subjects included 50 T2DM patients with CAD and 50 T2DM without CAD. All the subject venous blood was collected after overnight fasting for biochemical analysis. After the statistical analysis, the results showed significant difference between two groups as follows total bilirubin (0.32 ± 0.15; 0.90 ± 032; p = 0.000), direct bilirubin, indirect bilirubibn, Total Protein, Albumin, ALT, AST, HbA1c. Our finding implies that decreased serum bilirubin increases the risk of CAD in patients with T2DM and it shows inverse correlation between HbA1c and bilirubin.
- Treeprasertsuk, S., Lopez-Jimenez, F. and Lindor, K.D. (2011) Nonalcoholic Fatty Liver Disease and the Coronary Artery Disease. Digestive Diseases and Sciences, 56, 35-45. http://dx.doi.org/10.1007/s10620-010-1241-2
- Kotronen, A., Juurinen, L., Tiikkainen, M., Vehkavaara, S. and Yki-Järvinen, H. (2008) Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes. Gastroenterology, 135, 122-130. http://dx.doi.org/10.1053/j.gastro.2008.03.021
- Edmison, J. and McCullough, A.J. (2007) Pathogenesis of Non-Alcoholic Steatohepatitis: Human Data. Clinics in Liver Disease, 11, 75-104. http://dx.doi.org/10.1016/j.cld.2007.02.011
- Treeprasertsuk, S., Leverage, S., Adams, L.A., Lindor, K.D., St. Sauver, J. and Angulo, P. (2012) The Framingham Risk Score and Heart Disease in Nonalcoholic Fatty Liver Disease. Liver International, 32, 945-950. http://dx.doi.org/10.1111/j.1478-3231.2011.02753.x
- Kuzhandai velu, V., Jyothirmayi, B. and Kumar, J.S. (2011) Insulin Resistance and Alanine Amino Transaminase (ALT) Levels in First Degree Relatives of Type 2 Diabetes Mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 5, 143-147. http://dx.doi.org/10.1016/j.dsx.2012.02.011
- Gopal, N., Selvam, A. and Muddegowda, P.H. (2012) Serum Gamma Glutamyl Transferase levels in Obese South Indian Adults with Reference to Atherogenic Lipid Risk Factors and Lipid Peroxides. International Journal of Medical and Health Sciences, 1, 35-42.
- Majhi, S., Baral, N., Lamsal, M. and Mehta, K.D. (2006) De Ritis Ratio as Diagnostic Marker of Alcoholic Liver Disease. Nepal Medical College Journal, 8, 40-42.
- Arthi, M., Niranjan, G., Hanifah, M. and Srinivasan, A.R. (2011) Efficacy of De Ritis Ration in Diagnosing Liver Diseases in Puducherry Population. Advance Laboratory Medicine International, 1, 61-68.
- Mayer, M. (2000) Association of Serum Bilirubin Concentration with Risk of Coronary Artery Disease. Clinical Chemistry, 46, 1723-1727.
- Arumalla, V.K., Gopal, N. and Bn, R. (2012) Role of Serum Bilirubin in Coronary Artery Disease. International Journal of Medical and Health Sciences, 1, 56-62.
- Cersosimo, E. and DeFronzo, R.A. (2006) Insulin Resistance and Endothelial Dysfunction: The Road Map to Cardiovascular Diseases. Diabetes/Metabolism Research and Reviews, 22, 423-436. http://dx.doi.org/10.1002/dmrr.634